Table 3 Characteristics of children with and without laboratory tumor lysis syndrome
LTLS | ||||
|---|---|---|---|---|
Yes (n,%) | No (n,%) | P value | ||
Age (year) | n | 33 | 74 | 0.018 |
Min-Max (Median) | 2.3-15.7 (8.24) | 1.7-17.4 (10.49) | ||
Mean±SD | 8.07±3.6 | 9.93±3.7 | ||
Gender | Male | 24 (72.7) | 62 (83.8) | 0.184 |
Female | 9 (27.3) | 12 (16.2) | ||
Histopathological subgroups | Burkitt lymphoma | 26 (78.8) | 54 (73) | 0.765 |
Lymphoblastic lymphoma | 4 (12.2) | 15 (20.2) | ||
DLBCL | 2 (6) | 3 (4) | ||
ALCL | 1(3) | 2 (2.8) | ||
Stage | Stage 1-2 | 2 (6) | 23 (31.1) | 0.050 |
Stage 3 | 23 (69.8) | 37 (50.0) | ||
Stage 4 | 8 (24.2) | 14 (18.9) | ||
LDH level at presentation | n | 33 | 74 | 0.001 |
Min-Max (median) | 71-3969 (1332) | 140-9840 (537) | ||
(U/L) | Mean±SD | 1433.48±951.8 | 1433.48±951.8 | |
Bone marrow involvement | 6 (18.2) | 6 (8.1) | 0.183 | |
Renal involvement | 3 (9.1) | 8 (10.8) | 1.00 | |